Pages that link to "Q33223546"

The following pages link to Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension (Q33223546):

Displaying 24 items.

• Central serous chorioretinopathy: a pathogenetic model (Q24612211) (← links)
• The effects of dorzolamide 2% and dorzolamide/timolol fixed combination on retinal and optic nerve head blood flow in primary open-angle glaucoma patients. (Q33315242) (← links)
• Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits (Q33404316) (← links)
• Rational use of the fixed combination of dorzolamide - timolol in the management of raised intraocular pressure and glaucoma. (Q33492373) (← links)
• Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics (Q33513713) (← links)
• Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride. (Q33790393) (← links)
• A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients (Q34218659) (← links)
• The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma. (Q34296286) (← links)
• Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension (Q34571428) (← links)
• Pharmacotherapy of glaucoma (Q35138049) (← links)
• Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol (Q36024992) (← links)
• Topical drug therapy in glaucoma (Q36623753) (← links)
• Topical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertension (Q36677279) (← links)
• Pharmacological neuroprotection for glaucoma (Q36770323) (← links)
• Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma (Q37716010) (← links)
• Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients. (Q37750469) (← links)
• Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures (Q38074311) (← links)
• Effects of Dorzolamide on Retinal and Choroidal Blood Flow in the DBA/2J Mouse Model of Glaucoma (Q38762372) (← links)
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension (Q41953198) (← links)
• Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma (Q46899245) (← links)
• Vessel density in OCT angiography permits differentiation between normal and glaucomatous optic nerve heads. (Q55155305) (← links)
• Peripapillary microvasculature in the retinal nerve fiber layer in glaucoma by optical coherence tomography angiography: focal structural and functional correlations and diagnostic performance (Q59796103) (← links)
• Neuroprotection in glaucoma (Q60476041) (← links)
• Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature. (Q65002611) (← links)